Prevention and therapy in hereditary retinal degenerations

Documenta Ophthalmologica

Volumn 106, Issue 1, 2003, Pages 31-35

  Besch, Dorothea ^a   Zrenner, Eberhart ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Counselling; Prevention; Retinal degeneration; Therapy

Indexed keywords

ANTIOXIDANT; APOPTOSIS INHIBITOR; CALCIUM CHANNEL BLOCKING AGENT; GROWTH FACTOR; ISORHODOPSIN; PROTEIN; RETINOL PALMITATE; RIBOZYME; UNCLASSIFIED DRUG; XANTHOPHYLL; ZEAXANTHIN;

CLINICAL TRIAL; CONFERENCE PAPER; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; GENE IDENTIFICATION; GENE MAPPING; GENE THERAPY; GENETIC DISORDER; HEALTH SURVEY; HUMAN; LEBER CONGENITAL AMAUROSIS; LIVER TOXICITY; LONG TERM CARE; MOLECULAR CLONING; MOLECULAR GENETICS; NONHUMAN; PROSTHESIS; PROTEIN METABOLISM; RETINA; RETINA DEGENERATION; RETINITIS PIGMENTOSA; TECHNICAL AID; TRANSPLANTATION; USHER SYNDROME; VIRAL GENE DELIVERY SYSTEM; VISUAL AID; VITAMIN SUPPLEMENTATION;

DIET THERAPY; GENE THERAPY; GENETIC COUNSELING; GROWTH SUBSTANCES; HUMANS; PIGMENT EPITHELIUM OF EYE; RETINAL DEGENERATION;

EID: 0037230889     PISSN: 00124486     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022427813898     Document Type: Conference Paper

References (33)

1. Phelan JK, Bok D. A brief review of retinitis pigmentosa and the identified retinitis pigmentosa genes. Mol Vis 2000; 6: 116-124.
2. Nadine SD, Bennett J. Gene therapy and retinitis pigmentosa: Advances and future challenges. BioEssays 2001; 23: 662-8.
3. Ali RR, Sarra GM, Stephens C, Alwis MD, Bainbridge JW, Munro PM, Fauser S, Reichel MB, Kinnon C, Hunt DM, Bhattacharya SS, Thrasher AJ. Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy. Nat Genet 2000; 25(3): 306-10.
4. Sarra GM, Stephens C, De Alwis M, Bainbridge JWB, Smith AJ, Thrasher AJ, Ali RR. Gene replacement therapy in retinal degeneration slow (rds) mouse: The effect on retinal degeneration following partial transduction of the retina. Hum Mol Genet 2001; 21: 2353-61.
5. Lewin AS, Drenser KA, Hauswirth WW, Nishikawa S, Yasumura D, Flannery JG, LaVail MM. Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa. Nat Med 1998; 4: 967-71.
6. O'Neill B, Millington-Ward S, O'Reilly M, Tuoby G, Kiang, AS, Kenna PF, Humphreys P, Farrer GJ. Ribozyme-based therapeutic approaches for autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci 2000; 41: 2863-9.
7. Shaw LC, Skold A, Wong F, Petters R, Hauswirth W, Lewin AS. An allele-specific hammerhead ribozyme gene therapy for a porcine model of autosomal dominant retinitis pigmentosa. Mol Vis 2001; 7: 6-13.
8. Acland GM, Aguirre GD, Ray J, Zhang Q, Aleman TS, Cideciyan AV, Pearce-Kelling SE, Anand V, Zeng Y, Maguire AM, Jacobson SG, Hauswirth WW, Bennett J. Gene therapy restores vision in a canine model of childhood blindness. Nat Genet 2001, 28(1): 92-5.
9. Chong NH, Alexander RA, Waters L, Barnett KC, Bird AC, Luthert PJ. Repeated injections of a ciliary neurotrophic factor analogue leading to long-term photoreceptor survival in hereditary retinal degeneration. Invest Ophthalmol Vis Sci. 1999; 40(6): 1298-1305.
10. Liang FQ, Dejneka NS, Cohen DR, Krasnoperova NV, Lem J, Maguire AM, Dudus L, Fisher KJ, Bennett J. AAV-mediated delivery of ciliary neurotrophic factor prolongs photoreceptor survival in the rhodopsin knockout mouse. Mol Ther 2001, 3(2): 241-8.
11. Frasson M, Sahel JA, Fabre M, Simonutti M, Dreyfus H, Picaud S. Retinitis pigmentosa: Rod photoreceptor rescue by a calcium-channel blocker in the rd mouse. Nat Med 1999; 5(10): 1183-7.
12. Pearce-Kelling SE, Aleman TS, Nickle A, Laties AM, Aguirre GD, Jacobson SG, Acland GM. Calcium channel blocker D-cis-diltiazem does not slow retinal degeneration in the PDE6B mutant rcd1 canine model of retinitis pigmentosa. Mol Vis 2001; 7: 42-7.
13. Berson EL, Rosner M, Sandberg MA, Hayes KC, Nicholson BW, Weigel-DiFranco C, Willett W. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol 1993; 111: 761-72.
14. Sibulesky L, Hayes KC, Pronczuk A, Weigel-DiFranco C, Rosner B, Berson EL. Safety of <7500 RE (<25000 IU) vitamin A daily in adults with retinitis pigmentosa. Am J Clin Nutr 1999, 69(4): 656-63.
15. Li T, Sandberg MA, Pawlik BS, Rosner B, Hayes KC, Dryja TP, Berson EL. Effect of vitamin A supplementation on rhodopsin mutants threonine-17-methionine and proline-347-serine in transgenic mice and in cell cultures. Proc Natl Acad Sci USA 1998; 95(20): 11933-8.
16. Dagnelie G, Zorge IS, McDonald TM. Lutein improves visual function in some patients with retinal degeneration: A pilot study via the Internet. Optometry 2000; 71(3): 147-64.
17. Aleman TS, Duncan JL, Bieber ML, De Castro E, Marks DA, Gardner LM, Steinberg JD, Cideciyan AV, Maguire MG, Jacobson SG. Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome. Invest Ophthalmol Vis Sci 2001; 42(8): 1873-81.
18. Redmond TM, Yu S, Lee E, Bok D, Hamasaki D, Chen N, Goletz P, Ma JX, Crouch RK, Pfeifer K. Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle. Nat Genet 1998 20(4): 344-51.
19. Van Hoover JP, Aleman TS, He YG, Cideciyan AV, Kuksa V, Pittler SJ, Stone EM, Jacobson SG, Palcezwski K. Rapid restoration of visual pigment and function with oral retinoid in a mouse model of childhood blindness. Proc Natl Acad Sci USA 2000; 97: 8623-8.
20. Seeliger MW, Grimm C, Stahlberg F, Friedburg C, Jaissle G, Zrenner E, Guo H, Reme CE, Humphries P, Hofmann F, Biel M, Fariss RN, Redmond TM, Wenzel A. New views on RPE65 deficiency: The rod system is the source of vision in a mouse model of Leber congenital amaurosis. Nat Genet 2001; 29(1): 70-4.
21. Chong NHV, Bird AC. Management of inherited outer retinal dystrophies: Present and future. Br J Ophthalmol 1999; 83: 120-2.
22. Aramant R, Seiler M, Ehinger B, Bergström A, Gustavii B, Brundin P, Adolph AR. Transplantation of human embryonic retina to adult rat retina. Rest Neurol Neurosci 1990; 2: 9-22.
23. Gouras P., Du J, Kjeldbye H, Yamamoto S, Zack DJ. Long-term photoreceptor transplants in dystrophic and normal mouse retina. Ophthalmol Vis Sci 1994; 35: 3145-58.
24. Algvere PV, Berglin L, Gouras P, Sheng Y. Transplantation of fetal retinal pigment epithelium in age-related macular degeneration with subfoveal neovascularization. Graefes Arch Clin Exp Ophthalmol 1994; 232: 707-16.
25. Kaplan HJ, Tongalp HT, Berger AS, Wolf ML, Del Proire LV. Human photoreceptor transplantation in retinitis pigmentosa. A safety study. Arch Ophthalmol 1997; 115: 1168-72.
26. Woch G, Aramant RB, Seiler MJ, Sagdullaev BT, McCall MA. Retinal transplants restore visually evoked responses in rats with photoreceptor degeneration. Invest Ophthalmol Vis Sci 2001; 42: 1669-76.
27. Coffey PJ, Girman S, Wang SM, Hetherington L, Keegan DJ, Adamson P, Greeenwood J, Lund RD. Long-term preservation of cortically dependent visual function in RCS rats by transplantation. Nat Neurosci 2002; 5: 53-6.
28. Rizzo JF 3rd, Wyatt J, Humayun M, De Juan E, Liu W, Chow A, Eckmiller R, Zrenner E, Yagi T, Abrams G. Retinal prosthesis: An encouraging first decade with major challenges ahead. Ophthalmology 2001; 108(1): 13-4.
29. E. Zrenner. Will electronic retinal implants be able to restitute vision in the blind? Science 2002; 295: 1022-25.
30. Guenther E, Troeger B, Schlosshauer B, Zrenner E. Long-term survival of retinal cell cultures on retinal implant materials. Vision Research 1999; 39: 3988-94.
31. Stett A, Barth W, Weiss S, Haemmerle H, Zrenner E. Electrical multisite stimulation of the isolated chicken retina. Vision Res 2000; 40: 1785-95.
32. Krastel H. Richtlinien zur Anpassung von Kantenfiltern. Augenarzt 1997; 31: 155-9.
33. Auffarth GU, Tetz MR, Krastel H, Blankenagel A, Völcker HE. Indikationen und Erfolgsaussichten der Katarakt-Operation bei Patienten mit Retinitis pigmentosa. Ophthalmologe 1996, 93: 168-76.